Entry - #616487 - EPIDERMOLYSIS BULLOSA SIMPLEX 5D, GENERALIZED INTERMEDIATE, AUTOSOMAL RECESSIVE; EBS5D - OMIM
 
# 616487

EPIDERMOLYSIS BULLOSA SIMPLEX 5D, GENERALIZED INTERMEDIATE, AUTOSOMAL RECESSIVE; EBS5D


Alternative titles; symbols

EPIDERMOLYSIS BULLOSA SIMPLEX 5D, WITH NAIL DYSTROPHY
EPIDERMOLYSIS BULLOSA SIMPLEX WITH NAIL DYSTROPHY; EBSND


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
8q24.3 ?Epidermolysis bullosa simplex 5D, generalized intermediate, autosomal recessive 616487 AR 3 PLEC1 601282
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
HEAD & NECK
Mouth
- Intraoral blisters
SKIN, NAILS, & HAIR
Skin
- Blistering skin
- Plantar hyperkeratosis
- Scarring of blistered skin
- Hyperpigmentation of blistered skin
- Hyperkeratotic papules in blistered areas
Skin Histology
- Thin granular lining of keratin staining on blister floor
- Very low intraepidermal cleavage in basal cells
Electron Microscopy
- Hypoplastic hemidesmosomes
- Intraepidermal pseudo-junctional cleavage
Nails
- Dystrophic nails
MISCELLANEOUS
- Onset in childhood with exacerbation during puberty
MOLECULAR BASIS
- Caused by mutation in the plectin-1 gene (PLEC1, 601282.0014)
Epidermolysis bullosa simplex - PS131760 - 18 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
3q27.1 Epidermolysis bullosa simplex 6, generalized intermediate, with or without cardiomyopathy AD 3 617294 KLHL24 611295
6p12.1 Epidermolysis bullosa simplex 3, localized or generalized intermediate, with bp230 deficiency AR 3 615425 DST 113810
8q24.3 Epidermolysis bullosa simplex 5A, Ogna type AD 3 131950 PLEC1 601282
8q24.3 Epidermolysis bullosa simplex 5C, with pyloric atresia AR 3 612138 PLEC1 601282
8q24.3 Epidermolysis bullosa simplex 5B, with muscular dystrophy AR 3 226670 PLEC1 601282
8q24.3 ?Epidermolysis bullosa simplex 5D, generalized intermediate, autosomal recessive AR 3 616487 PLEC1 601282
11p15.5 Epidermolysis bullosa simplex 7, with nephropathy and deafness AR 3 609057 CD151 602243
11q22.3 Epidermolysis bullosa simplex 4, localized or generalized intermediate, autosomal recessive AR 3 615028 EXPH5 612878
12q13.13 Epidermolysis bullosa simplex 2F, with mottled pigmentation AD 3 131960 KRT5 148040
12q13.13 Epidermolysis bullosa simplex 2A, generalized severe AD 3 619555 KRT5 148040
12q13.13 Epidermolysis bullosa simplex 2D, generalized, intermediate or severe, autosomal recessive AR 3 619599 KRT5 148040
12q13.13 Epidermolysis bullosa simplex 2C, localized AD 3 619594 KRT5 148040
12q13.13 Epidermolysis bullosa simplex 2E, with migratory circinate erythema AD 3 609352 KRT5 148040
12q13.13 Epidermolysis bullosa simplex 2B, generalized intermediate AD 3 619588 KRT5 148040
17q21.2 Epidermolysis bullosa simplex 1A, generalized severe AD 3 131760 KRT14 148066
17q21.2 Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive AR 3 601001 KRT14 148066
17q21.2 Epidermolysis bullosa simplex 1B, generalized intermediate AD 3 131900 KRT14 148066
17q21.2 Epidermolysis bullosa simplex 1C, localized AD 3 131800 KRT14 148066

TEXT

A number sign (#) is used with this entry because of evidence that autosomal recessive generalized intermediate epidermolysis bullosa simplex 5D (EBS5D) is caused by homozygous or compound heterozygous mutation in the PLEC gene (601282) on chromosome 8q24.


Description

Autosomal recessive generalized intermediate epidermolysis bullosa simplex 5D (EBS5D) is characterized by generalized skin blistering that heals with scarring and hyperpigmentation. Nail dystrophy is severe. Mucous membranes, heart, and muscle are spared (Gostynska et al., 2015).

For a discussion of genetic heterogeneity of the subtypes of EBS, see EBS1A (131760).


Clinical Features

Gostynska et al. (2015) reported 2 sisters from a consanguineous Turkish family who had skin blistering with sparing of the mucous membranes as well as severe nail dystrophy, without cardiac or skeletal muscle involvement, and mutation in the PLEC gene. The proband, first examined at 27 years of age, had developed mild foot blisters after walking at 1.5 years of age. Fingernails and toenails were dystrophic by 3 years of age. Blistering became generalized with pruritus during puberty at age 14, and lesions healed with scarring and hyperpigmentation. Examination revealed excoriated and verrucous papules and intact blisters, most pronounced on the distal extremities, as well as focal plantar hyperkeratosis and severely dystrophic nails. Teeth and hair were normal. Her 26-year-old sister had a similar history and distribution of progressive skin lesions but displayed less pronounced hyperkeratotic papules and plantar hyperkeratosis, possibly due to having less pruritus. Neurologic and cardiologic evaluation in the older sister revealed no evidence of muscular dystrophy or cardiac pathology; neither sister exhibited any signs of muscular dystrophy or cardiomyopathy at 29 and 30 years of age, respectively. Immunofluorescence antigen mapping of lesional skin showed a thin granular lining of keratin staining on the blister floor, revealing very low intraepidermal cleavage in basal cells, consistent with EBS. Transmission electron microscopy showed hypoplastic hemidesmosomes and intraepidermal pseudojunctional cleavage, with the plasma membrane of basal cells visible on the blister floor.

Tu et al. (2020) reported 2 unrelated patients who had generalized EBS with nail dystrophy and mutation in the PLEC gene. The 31-year-old woman and 18-year-old man both had generalized erythematous blistering and erosions since birth, with hyperpigmented patches on the trunk and extremities. Both had blisters within the oral cavity, palmoplantar keratoderma, and dystrophy of all 20 nails. Neither had muscle weakness, hoarseness, ocular lesions, or other extracutaneous manifestations. Transmission electron microscopy showed hypoplastic hemidesmosomes in both patients; the woman also had focal reduplication of the lamina densa and the man had vesicles in basal cells. Immunofluorescence studies showed near-complete absence of plectin at the dermoepidermal junction.


Inheritance

The transmission pattern of EBS5D in the family reported by Gostynska et al. (2015) was consistent with autosomal recessive inheritance.


Molecular Genetics

In 2 sisters with EBS and nail dystrophy (EBSND) from a consanguineous Turkish family, Gostynska et al. (2015) analyzed the candidate gene PLEC1 and identified homozygosity for a nonsense mutation (R16X; 601282.0014) present only in the 1a isoform. Quantitative RT-PCR of cultured skin keratinocytes from the sisters showed reduced transcription of 1a compared to controls. Because isoform 1a is not expressed in either striated or cardiac muscle tissue, Gostynska et al. (2015) stated that they did not expect muscular dystrophy or cardiomyopathy to develop in these patients.

By whole-exome sequencing (WES) evaluating 21 known EBS-associated genes in a 31-year-old woman with EBSND, Tu et al. (2020) identified compound heterozygosity for a nonsense mutation (R2319X; 601282.0013) and a missense mutation (L319P; 601282.0015) in the PLEC gene. WES in a similarly affected unrelated 18-year-old man revealed compound heterozygosity for the same L319P mutation and a nonsense mutation (W936X; 601282.0016). Sanger sequencing confirmed segregation in the families.


REFERENCES

  1. Gostynska, K. B., Nijenhuis, M., Lemmink, H., Pas, H. H., Pasmooij, A. M. G., Lang, K. K., Castanon, M. J., Wiche, G., Jonkman, M. F. Mutation in exon 1a of PLEC, leading to disruption of plectin isoform 1a, causes autosomal-recessive skin-only epidermolysis bullosa simplex. Hum. Molec. Genet. 24: 3155-3162, 2015. [PubMed: 25712130, related citations] [Full Text]

  2. Tu, W.-T., Chen, P.-C., Hou, P.-C., Huang, H.-Y., Wang, J.-Y., Chao, S.-C., Lee, J. Y., McGrath, J. A., Natsuga, K., Hsu, C.-K. Plectin missense mutation p.leu319pro in the pathogenesis of autosomal recessive epidermolysis bullosa simplex. Acta Derm. Venereol. 100: adv00242, 2020. [PubMed: 32725257, related citations] [Full Text]


Contributors:
Marla J. F. O'Neill - updated : 04/19/2022
Creation Date:
Marla J. F. O'Neill : 7/27/2015
alopez : 04/19/2022
alopez : 11/01/2021
alopez : 10/29/2021
alopez : 07/28/2015
alopez : 7/27/2015
mcolton : 7/27/2015
mcolton : 7/27/2015

# 616487

EPIDERMOLYSIS BULLOSA SIMPLEX 5D, GENERALIZED INTERMEDIATE, AUTOSOMAL RECESSIVE; EBS5D


Alternative titles; symbols

EPIDERMOLYSIS BULLOSA SIMPLEX 5D, WITH NAIL DYSTROPHY
EPIDERMOLYSIS BULLOSA SIMPLEX WITH NAIL DYSTROPHY; EBSND


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
8q24.3 ?Epidermolysis bullosa simplex 5D, generalized intermediate, autosomal recessive 616487 Autosomal recessive 3 PLEC1 601282

TEXT

A number sign (#) is used with this entry because of evidence that autosomal recessive generalized intermediate epidermolysis bullosa simplex 5D (EBS5D) is caused by homozygous or compound heterozygous mutation in the PLEC gene (601282) on chromosome 8q24.


Description

Autosomal recessive generalized intermediate epidermolysis bullosa simplex 5D (EBS5D) is characterized by generalized skin blistering that heals with scarring and hyperpigmentation. Nail dystrophy is severe. Mucous membranes, heart, and muscle are spared (Gostynska et al., 2015).

For a discussion of genetic heterogeneity of the subtypes of EBS, see EBS1A (131760).


Clinical Features

Gostynska et al. (2015) reported 2 sisters from a consanguineous Turkish family who had skin blistering with sparing of the mucous membranes as well as severe nail dystrophy, without cardiac or skeletal muscle involvement, and mutation in the PLEC gene. The proband, first examined at 27 years of age, had developed mild foot blisters after walking at 1.5 years of age. Fingernails and toenails were dystrophic by 3 years of age. Blistering became generalized with pruritus during puberty at age 14, and lesions healed with scarring and hyperpigmentation. Examination revealed excoriated and verrucous papules and intact blisters, most pronounced on the distal extremities, as well as focal plantar hyperkeratosis and severely dystrophic nails. Teeth and hair were normal. Her 26-year-old sister had a similar history and distribution of progressive skin lesions but displayed less pronounced hyperkeratotic papules and plantar hyperkeratosis, possibly due to having less pruritus. Neurologic and cardiologic evaluation in the older sister revealed no evidence of muscular dystrophy or cardiac pathology; neither sister exhibited any signs of muscular dystrophy or cardiomyopathy at 29 and 30 years of age, respectively. Immunofluorescence antigen mapping of lesional skin showed a thin granular lining of keratin staining on the blister floor, revealing very low intraepidermal cleavage in basal cells, consistent with EBS. Transmission electron microscopy showed hypoplastic hemidesmosomes and intraepidermal pseudojunctional cleavage, with the plasma membrane of basal cells visible on the blister floor.

Tu et al. (2020) reported 2 unrelated patients who had generalized EBS with nail dystrophy and mutation in the PLEC gene. The 31-year-old woman and 18-year-old man both had generalized erythematous blistering and erosions since birth, with hyperpigmented patches on the trunk and extremities. Both had blisters within the oral cavity, palmoplantar keratoderma, and dystrophy of all 20 nails. Neither had muscle weakness, hoarseness, ocular lesions, or other extracutaneous manifestations. Transmission electron microscopy showed hypoplastic hemidesmosomes in both patients; the woman also had focal reduplication of the lamina densa and the man had vesicles in basal cells. Immunofluorescence studies showed near-complete absence of plectin at the dermoepidermal junction.


Inheritance

The transmission pattern of EBS5D in the family reported by Gostynska et al. (2015) was consistent with autosomal recessive inheritance.


Molecular Genetics

In 2 sisters with EBS and nail dystrophy (EBSND) from a consanguineous Turkish family, Gostynska et al. (2015) analyzed the candidate gene PLEC1 and identified homozygosity for a nonsense mutation (R16X; 601282.0014) present only in the 1a isoform. Quantitative RT-PCR of cultured skin keratinocytes from the sisters showed reduced transcription of 1a compared to controls. Because isoform 1a is not expressed in either striated or cardiac muscle tissue, Gostynska et al. (2015) stated that they did not expect muscular dystrophy or cardiomyopathy to develop in these patients.

By whole-exome sequencing (WES) evaluating 21 known EBS-associated genes in a 31-year-old woman with EBSND, Tu et al. (2020) identified compound heterozygosity for a nonsense mutation (R2319X; 601282.0013) and a missense mutation (L319P; 601282.0015) in the PLEC gene. WES in a similarly affected unrelated 18-year-old man revealed compound heterozygosity for the same L319P mutation and a nonsense mutation (W936X; 601282.0016). Sanger sequencing confirmed segregation in the families.


REFERENCES

  1. Gostynska, K. B., Nijenhuis, M., Lemmink, H., Pas, H. H., Pasmooij, A. M. G., Lang, K. K., Castanon, M. J., Wiche, G., Jonkman, M. F. Mutation in exon 1a of PLEC, leading to disruption of plectin isoform 1a, causes autosomal-recessive skin-only epidermolysis bullosa simplex. Hum. Molec. Genet. 24: 3155-3162, 2015. [PubMed: 25712130] [Full Text: https://doi.org/10.1093/hmg/ddv066]

  2. Tu, W.-T., Chen, P.-C., Hou, P.-C., Huang, H.-Y., Wang, J.-Y., Chao, S.-C., Lee, J. Y., McGrath, J. A., Natsuga, K., Hsu, C.-K. Plectin missense mutation p.leu319pro in the pathogenesis of autosomal recessive epidermolysis bullosa simplex. Acta Derm. Venereol. 100: adv00242, 2020. [PubMed: 32725257] [Full Text: https://doi.org/10.2340/00015555-3600]


Contributors:
Marla J. F. O'Neill - updated : 04/19/2022

Creation Date:
Marla J. F. O'Neill : 7/27/2015

Edit History:
alopez : 04/19/2022
alopez : 11/01/2021
alopez : 10/29/2021
alopez : 07/28/2015
alopez : 7/27/2015
mcolton : 7/27/2015
mcolton : 7/27/2015